Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Jun 15;89(12):5251–5255. doi: 10.1073/pnas.89.12.5251

Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism.

P W Ladenson 1, S I Sherman 1, K L Baughman 1, P E Ray 1, A M Feldman 1
PMCID: PMC49269  PMID: 1376915

Abstract

Thyroid hormone effects on myocardial gene expression have been well defined in animal models, but their relationship to the pathogenesis of cardiac dysfunction in hypothyroid humans has been uncertain. We evaluated a profoundly hypothyroid young man with dilated cardiomyopathy. Before and during 9 months of thyroxine therapy, serial assessment of myocardial performance documented substantial improvements in the left ventricular ejection fraction (16-37%), left ventricular end-diastolic diameter (7.8-5.9 cm), and cardiac index (1.4-2.7 liters.min-1.m-2). Steady-state levels of mRNAs encoding selected cardiac proteins were measured in biopsy samples obtained before and after thyroxine replacement. In comparison with myocardium from nonfailing control hearts, this patient's pretreatment alpha-myosin heavy-chain mRNA level was substantially lower, the atrial natriuretic factor mRNA level was markedly elevated, and the phospholamban mRNA level was decreased. All of these derangements were reversed 9 months after restoration of euthyroidism. These observations in an unusual patient with profound myxedema and cardiac dilatation permit correlation between the reversible changes in myocardial function and steady-state mRNA levels in a cardiomyopathy. They suggest that alterations in gene expression in the dilated myopathic heart may be correctable when a treatable cause is identified.

Full text

PDF
5251

Images in this article

5252Image
on p.5252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amidi M., Leon D. F., DeGroot W. J., Kroetz F. W., Leonard J. J. Effect of the thyroid state on myocardial contractility and ventricular ejection rate in man. Circulation. 1968 Aug;38(2):229–239. doi: 10.1161/01.cir.38.2.229. [DOI] [PubMed] [Google Scholar]
  2. Chapoy P. R., Angelini C., Brown W. J., Stiff J. E., Shug A. L., Cederbaum S. D. Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome. N Engl J Med. 1980 Dec 11;303(24):1389–1394. doi: 10.1056/NEJM198012113032403. [DOI] [PubMed] [Google Scholar]
  3. Dillmann W. H., Rohrer D., Popovich B., Barrieux A. Thyroid hormone induced changes in cardiac proteins and mRNAs. Horm Metab Res Suppl. 1987;17:26–29. [PubMed] [Google Scholar]
  4. Feldman A. M., Becker L. C., Llewellyn M. P., Baughman K. L. Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure. Am Heart J. 1988 Sep;116(3):771–777. doi: 10.1016/0002-8703(88)90336-5. [DOI] [PubMed] [Google Scholar]
  5. Feldman A. M., Cates A. E., Bristow M. R., Van Dop C. Altered expression of alpha-subunits of G proteins in failing human hearts. J Mol Cell Cardiol. 1989 Apr;21(4):359–365. doi: 10.1016/0022-2828(89)90646-9. [DOI] [PubMed] [Google Scholar]
  6. Feldman A. M., Fivush B., Zahka K. G., Ouyang P., Baughman K. L. Congestive cardiomyopathy in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1988 Jan;11(1):76–79. doi: 10.1016/s0272-6386(88)80180-x. [DOI] [PubMed] [Google Scholar]
  7. Feldman A. M., Ray P. E., Bristow M. R. Expression of alpha-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction. J Mol Cell Cardiol. 1991 Dec;23(12):1355–1358. doi: 10.1016/0022-2828(91)90182-l. [DOI] [PubMed] [Google Scholar]
  8. Feldman A. M., Ray P. E., Silan C. M., Mercer J. A., Minobe W., Bristow M. R. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 1991 Jun;83(6):1866–1872. doi: 10.1161/01.cir.83.6.1866. [DOI] [PubMed] [Google Scholar]
  9. GRAETTINGER J. S., MUENSTER J. J., CHECCHIA C. S., GRISSOM R. L., CAMPBELL J. A. A correlation of clinical and hemodynamic studies in patients with hypothyroidism. J Clin Invest. 1958 Apr;37(4):502–510. doi: 10.1172/JCI103631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gustafson T. A., Markham B. E., Morkin E. Effects of thyroid hormone on alpha-actin and myosin heavy chain gene expression in cardiac and skeletal muscles of the rat: measurement of mRNA content using synthetic oligonucleotide probes. Circ Res. 1986 Aug;59(2):194–201. doi: 10.1161/01.res.59.2.194. [DOI] [PubMed] [Google Scholar]
  11. Kobilka B. K., Frielle T., Dohlman H. G., Bolanowski M. A., Dixon R. A., Keller P., Caron M. G., Lefkowitz R. J. Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem. 1987 May 25;262(15):7321–7327. [PubMed] [Google Scholar]
  12. Kurabayashi M., Tsuchimochi H., Komuro I., Takaku F., Yazaki Y. Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium. J Clin Invest. 1988 Aug;82(2):524–531. doi: 10.1172/JCI113627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ladenson P. W., Bloch K. D., Seidman J. G. Modulation of atrial natriuretic factor by thyroid hormone: messenger ribonucleic acid and peptide levels in hypothyroid, euthyroid, and hyperthyroid rat atria and ventricles. Endocrinology. 1988 Jul;123(1):652–657. doi: 10.1210/endo-123-1-652. [DOI] [PubMed] [Google Scholar]
  14. Levine M. A., Feldman A. M., Robishaw J. D., Ladenson P. W., Ahn T. G., Moroney J. F., Smallwood P. M. Influence of thyroid hormone status on expression of genes encoding G protein subunits in the rat heart. J Biol Chem. 1990 Feb 25;265(6):3553–3560. [PubMed] [Google Scholar]
  15. Mercadier J. J., Bouveret P., Gorza L., Schiaffino S., Clark W. A., Zak R., Swynghedauw B., Schwartz K. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ Res. 1983 Jul;53(1):52–62. doi: 10.1161/01.res.53.1.52. [DOI] [PubMed] [Google Scholar]
  16. Midei M. G., DeMent S. H., Feldman A. M., Hutchins G. M., Baughman K. L. Peripartum myocarditis and cardiomyopathy. Circulation. 1990 Mar;81(3):922–928. doi: 10.1161/01.cir.81.3.922. [DOI] [PubMed] [Google Scholar]
  17. Nagai R., Zarain-Herzberg A., Brandl C. J., Fujii J., Tada M., MacLennan D. H., Alpert N. R., Periasamy M. Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2966–2970. doi: 10.1073/pnas.86.8.2966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pombo J. F., Troy B. L., Russell R. O., Jr Left ventricular volumes and ejection fraction by echocardiography. Circulation. 1971 Apr;43(4):480–490. doi: 10.1161/01.cir.43.4.480. [DOI] [PubMed] [Google Scholar]
  19. Rimailho A., Bouchard P., Schaison G., Richard C., Auzépy P. Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level. Am Heart J. 1985 Mar;109(3 Pt 1):611–613. doi: 10.1016/0002-8703(85)90579-4. [DOI] [PubMed] [Google Scholar]
  20. Rodbard D., Fujita T., Rodbard S. Estimation of thyroid function by timing the arterial sounds. JAMA. 1967 Sep 11;201(11):884–887. [PubMed] [Google Scholar]
  21. Rodeheffer R. J., Gerstenblith G., Becker L. C., Fleg J. L., Weisfeldt M. L., Lakatta E. G. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation. 1984 Feb;69(2):203–213. doi: 10.1161/01.cir.69.2.203. [DOI] [PubMed] [Google Scholar]
  22. Saito Y., Nakao K., Arai H., Nishimura K., Okumura K., Obata K., Takemura G., Fujiwara H., Sugawara A., Yamada T. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest. 1989 Jan;83(1):298–305. doi: 10.1172/JCI113872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Samuels H. H., Forman B. M., Horowitz Z. D., Ye Z. S. Regulation of gene expression by thyroid hormone. Annu Rev Physiol. 1989;51:623–639. doi: 10.1146/annurev.ph.51.030189.003203. [DOI] [PubMed] [Google Scholar]
  24. Suko J. The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits. J Physiol. 1973 Feb;228(3):563–582. doi: 10.1113/jphysiol.1973.sp010100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Waber L. J., Valle D., Neill C., DiMauro S., Shug A. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr. 1982 Nov;101(5):700–705. doi: 10.1016/s0022-3476(82)80294-1. [DOI] [PubMed] [Google Scholar]
  26. Wang A. M., Doyle M. V., Mark D. F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9717–9721. doi: 10.1073/pnas.86.24.9717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Williams L. T., Lefkowitz R. J., Watanabe A. M., Hathaway D. R., Besch H. R., Jr Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem. 1977 Apr 25;252(8):2787–2789. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES